Lyell Immunopharma, Inc. (LYEL)
23.76
+0.83
(+3.62%)
USD |
NASDAQ |
Jan 16, 16:00
23.86
+0.10
(+0.42%)
After-Hours: 20:00
Lyell Immunopharma Shareholders Equity (Annual): 382.82M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Insmed, Inc. | 285.38M |
| Nektar Therapeutics | 60.74M |
| GT Biopharma, Inc. | -1.67M |
| Ionis Pharmaceuticals, Inc. | 588.35M |
| Regeneron Pharmaceuticals, Inc. | 29.35B |